Full service clinical trial execution, regulatory consulting, and strategic planning to rapidly advance development, approval, and commercialization of your revolutionary therapies around the globe.

Veristat is a full-service Contract Research Organization (CRO) that specializes in advancing complex and novel therapies through a science-first approach. The company integrates strategic planning, regulatory strategy, and clinical trial execution, boasting extensive experience with over 350 rare disease projects and more than 375 biologics projects. Veristat's team of scientific experts is adept at managing full-service clinical trials, regulatory affairs, and providing strategic consulting, which is crucial for navigating the complexities of drug development and regulatory submissions. Their expertise spans various therapeutic areas, including oncology, neurology, immunology, and infectious diseases, ensuring tailored support for each client's unique needs.

In addition to clinical trial management, Veristat emphasizes the importance of project management throughout the clinical development process. Their project managers are skilled in risk mitigation, timeline management, and ensuring compliance with regulatory standards. The company also offers services in patient recruitment, safety pharmacovigilance, and data management, which are essential for maintaining the integrity and success of clinical trials. By leveraging their comprehensive capabilities, Veristat aims to facilitate the successful transition of therapies from development to market, ultimately improving patient outcomes and advancing healthcare solutions.

Canada

Veristat is a Massachusetts-based CRO that provides services such as regulatory consulting, medical writing, and monitoring for the pharmaceutical industry.

Veristat

Company Details